Candidemia research hub

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

This study is testing a new medicine, Fosmanogepix, for serious fungal infections called candidemia or invasive candidiasis. It compares the new medicine to standard treatments to see if it's safe and works just as well. We're looking for adults diagnosed with these infections.